Abstract
Background:
Seizures in elderly populations present unique challenges, with potential gender-specific variations in presentation and outcomes. This study aimed to compare the characteristics of seizures between elderly male and female patients, focusing on etiology, radiological features, and electroencephalographic (EEG) findings.
Methodology:
This observational cross-sectional study included 75 patients (40 males, 35 females) aged ≥60 years presenting with seizures at a tertiary care center. All patients underwent detailed clinical evaluation, neuroimaging (magnetic resonance imaging), and EEG studies. Gender-specific differences in various parameters were analyzed using appropriate statistical tests.
Results:
While cerebrovascular disease was the leading cause in both groups (40.0% males, 34.3% females), neurodegenerative disorders showed significantly higher prevalence in females (31.4% vs. 20.0%, P = 0.042). Radiological findings revealed higher rates of cortical infarcts in males (35.0%) and white matter changes in females (37.1%). EEG findings were comparable between genders, with focal epileptiform discharges being the most common (55.0% males and 51.4% females). Treatment outcomes were similar, with complete seizure control achieved in 65.0% of males and 68.6% of females.
Conclusions:
The study demonstrates significant gender-specific patterns in seizure etiology among elderly patients, particularly regarding neurodegenerative disorders. While radiological and EEG findings showed subtle differences, treatment outcomes were comparable between genders. These findings suggest the importance of gender-specific considerations in the evaluation and management of elderly patients with seizures.
Keywords: Antiepileptic drugs, cerebrovascular disease, elderly, electroencephalography, epilepsy, gender differences, magnetic resonance imaging, neurodegenerative disorders, seizures, treatment outcome
Résumé
Contexte:
Les crises d’épilepsie chez les personnes âgées posent des défis cliniques particuliers, souvent influencés par des étiologies sous-jacentes et des comorbidités. Comprendre les variations liées au sexe dans les caractéristiques des crises est essentiel pour optimiser les strategies diagnostiques et thérapeutiques.
Objectif:
Comparer les caractéristiques des crises d’épilepsie entre les patients âgés de sexe masculin et féminin, en mettant l’accent sur l’étiologie, les caractéristiques radiologiques et les résultats électroencéphalographiques (EEG).
Méthodologie:
Cette étude observationnelle transversale a inclus 75 patients (40 hommes, 35 femmes) âgés de 60 ans ou plus, consultant pour des crises d’épilepsie dans un centre hospitalier universitaire. Tous les participants ont bénéficié d’un examen clinique approfondi, d’une imagerie par résonance magnétique (IRM) et d’une étude EEG. Les différences entre les sexes ont été analysées à l’aide de tests statistiques appropriés.
Résultats:
Étiologie : La maladie cérébrovasculaire était la cause principale dans les deux groupes (hommes : 40,0 %, femmes : 34,3 %). Toutefois, les troubles neurodégénératifs étaient significativement plus fréquents chez les femmes (31,4 % contre 20,0 %, P = 0,042).
Résultats radiologiques:
Les infarctus corticaux étaient plus fréquents chez les hommes (35,0 %), tandis que les femmes présentaient davantage d’altérations de la substance blanche (37,1 %).
Résultats EEG:
Les décharges épileptiformes focales étaient les anomalies les plus fréquentes, observées chez 55,0 % des hommes et 51,4 % des femmes, sans différence significative entre les sexes.
Résultats thérapeutiques:
Le contrôle complet des crises a été obtenu chez 65,0 % des hommes et 68,6 % des femmes, suggérant une efficacité thérapeutique comparable entre les sexes.
Conclusions:
Cette étude met en évidence des différences notables selon le sexe dans l’étiologie des crises chez les patients âgés, notamment une prévalence plus élevée des troubles neurodégénératifs chez les femmes. Les résultats radiologiques et EEG ont montré des variations subtiles, tandis que les résultats du traitement étaient similaires. Ces données soulignent l’importance d’une approche tenant compte du sexe dans l’évaluation et la prise en charge des crises d’épilepsie chez les personnes âgées.
Mots-clés: Crises d’épilepsie, personnes âgées, différences selon le sexe, maladie cérébrovasculaire, troubles neurodégénératifs, EEG, IRM, épilepsie, médicaments antiépileptiques, résultat thérapeutique
INTRODUCTION
Seizures in the elderly population represent a significant neurological challenge that has gained increasing attention as global demographics shift toward an aging population.[1] The incidence of new-onset seizures is notably higher in individuals over 65 years of age compared to younger adults, with recent epidemiological studies indicating rates as high as 150 per 100,000 person-years in this age group, representing a 30% increase from previous decades.[2]
The etiology of seizures in the elderly presents a complex spectrum distinctly different from that observed in younger populations. While idiopathic seizures predominate in younger adults, elderly patients more commonly experience seizures secondary to identifiable pathologies.[3] Recent meta-analyses have confirmed cerebrovascular disease as the leading cause, accounting for approximately 45%–60% of cases, followed by neurodegenerative disorders, brain tumor, and metabolic disturbances.[4] Contemporary research has revealed significant gender-specific variations in these etiological patterns, with women showing a nearly twofold higher prevalence of seizures associated with Alzheimer’s disease and men demonstrating increased incidence of poststroke epilepsy, particularly in the 1st year following the event.[5]
Radiological features play a crucial role in understanding and managing seizures in the elderly population. Recent advances in neuroimaging techniques, including high-resolution 7T magnetic resonance imaging (MRI) and advanced functional neuroimaging, have revealed previously undetectable structural and functional differences between male and female patients with seizures.[6] These differences extend beyond obvious pathological findings to include variations in network connectivity patterns, hippocampal subfield volumes, and region-specific patterns of cerebral atrophy. Modern quantitative imaging analyses have demonstrated gender-specific patterns in white matter integrity and cortical thickness that may influence seizure susceptibility and progression.[7]
Electroencephalographic (EEG) findings in elderly patients with seizures present unique characteristics and challenges in interpretation. Recent studies utilizing advanced EEG analysis techniques, including quantitative EEG and machine learning approaches, have revealed age-related changes in background activity that significantly impact the identification of epileptiform discharges.[8] Contemporary research has identified gender-specific variations in EEG patterns, including differences in seizure onset zones, network propagation patterns, and treatment responses, though these findings continue to evolve with advancing technology.[9]
The clinical presentation of seizures in the elderly often differs from that observed in younger populations, with recent large-scale studies highlighting a higher prevalence of subtle or atypical manifestations that can lead to delayed diagnosis or misdiagnosis.[10] These presentations may vary between males and females, potentially influenced by newly identified genetic factors, age-related pharmacokinetic changes, and gender-specific comorbidities.
Understanding these gender-specific differences in seizure characteristics among elderly patients has important implications for:
Precision medicine approaches to diagnosis and treatment
Optimization of advanced neuroimaging protocols
Selection of antiepileptic medications based on gender-specific pharmacokinetics
Management of comorbidities with consideration of gender-specific risk factors
Implementation of targeted prevention strategies
Prediction of long-term outcomes and quality of life.
The present study aims to address current knowledge gaps by conducting a comparative analysis of seizures in elderly male and female patients, with particular emphasis on etiological factors, radiological features, and EEG findings. This comprehensive evaluation will contribute to our understanding of gender-specific aspects of seizures in the elderly and potentially inform more targeted therapeutic approaches in the era of precision medicine.
METHODOLOGY
Study design and setting
This observational cross-sectional study was conducted in the Department of Medicine at our tertiary care center over 18 months. The study protocol was approved by the Institutional Ethics Committee, and written informed consent was obtained from all participants or their legal guardians.
Study population
A total of 75 elderly patients (aged 60 years and above) presenting with seizures were included in the study. The study population was divided into two groups based on gender. Patients with a history of psychogenic nonepileptic seizures, those unable to undergo MRI, and those refusing consent were excluded from the study.
Sample size and sampling method
The sample size of 75 was calculated based on previous studies with similar objectives, considering a confidence interval of 95% and a margin of error of 5%. A consecutive sampling technique was employed to recruit eligible patients who presented to the neurology outpatient department or emergency services.
Data collection
A detailed clinical history was obtained from all patients using a structured proforma. The collected data included:
Demographic details
Seizure characteristics (type, frequency, duration)
Past medical history
Family history
Current medications
Associated comorbidities
Physical and neurological examination findings.
Clinical assessment
All patients underwent comprehensive neurological examination by experienced neurologists. Seizure classification was performed according to the International League Against Epilepsy 2017 classification system. The etiology was determined based on clinical findings, laboratory investigations, imaging studies, and other relevant investigations.
Laboratory investigations
Standard laboratory investigations were performed for all patients, including:
Complete blood count
Serum electrolytes
Blood glucose
Liver and renal function tests
Thyroid function tests
Serum calcium and magnesium levels.
Radiological assessment
All patients underwent radiological evaluation including:
MRI of the brain (1.5 Tesla) with standard protocols
Computed tomography scan of the brain (when indicated)
MR spectroscopy and contrast studies (in selected cases).
The MRI sequences included T1-weighted, T2-weighted, fluid-attenuated inversion recovery, diffusion-weighted imaging, and gradient echo images. Two experienced neuroradiologists, blinded to the clinical details, independently evaluated the imaging findings. Any discrepancies were resolved through consensus.
Electroencephalographic recording and analysis
Digital EEG recordings were performed using a 32-channel EEG system following the international 10–20 system of electrode placement. Both routine and sleep-deprived EEG recordings were obtained when indicated. Each EEG recording lasted for a minimum of 30 min and included:
Standard activation procedures (hyperventilation and photic stimulation)
Both awake and drowsy states
Natural sleep when possible.
EEG analysis was performed independently by two qualified neurophysiologists who were blinded to the clinical and radiological findings. The following parameters were assessed:
Background activity
Presence and type of epileptiform discharges
Focal versus generalized abnormalities
Post-ictal changes
Sleep architecture (when applicable).
Data analysis
Statistical analysis was performed using SPSS version 25.0 (IBM corporation, Armonk, Newyork, USA). Descriptive statistics were presented as frequencies, percentages, means ± standard deviations, and medians with interquartile ranges as appropriate. Comparative analysis between male and female groups was performed using:
Chi-square test for categorical variables
Student’s t-test for normally distributed continuous variables
Mann–Whitney U-test for non-normally distributed continuous variables.
P < 0.05 was considered statistically significant. Multivariate analysis was performed to adjust for potential confounding factors.
Quality control measures
To ensure data quality and reliability:
Standardized data collection forms were used
Regular calibration of EEG and imaging equipment was performed
Independent assessment by multiple specialists
Regular data audits
Adherence to standard operating procedures.
Ethical considerations
The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Patient confidentiality was maintained throughout the study period. Patients were free to withdraw from the study at any time without affecting their standard of care. All investigations were performed as part of routine clinical care, and no additional financial burden was placed on the patients.
RESULTS
The study included 75 elderly patients with seizures, comprising 40 males and 35 females. The demographic data showed comparable characteristics between genders, with mean ages of 68.5 ± 6.2 years for males and 70.2 ± 5.8 years for females (P = 0.245). The duration of epilepsy was similar in both groups (males: 4.2 ± 2.8 years; females: 3.8 ± 2.5 years; P = 0.512). Common comorbidities were similarly distributed, with hypertension being the most prevalent (70.0% in males, and 71.4% in females) [Table 1].
Table 1.
Demographic and clinical characteristics
| Characteristic | Males (n=40) | Females (n=35) | P |
|---|---|---|---|
| Age (years)* | 68.5±6.2 | 70.2±5.8 | 0.245 |
| Duration of epilepsy (years)* | 4.2±2.8 | 3.8±2.5 | 0.512 |
| Comorbidities, n (%) | |||
| Hypertension | 28 (70.0) | 25 (71.4) | 0.892 |
| Diabetes mellitus | 22 (55.0) | 20 (57.1) | 0.854 |
| Coronary artery disease | 18 (45.0) | 12 (34.3) | 0.342 |
| Dyslipidemia | 15 (37.5) | 14 (40.0) | 0.824 |
*Values presented as mean±SD. SD=Standard deviation
Regarding etiology, cerebrovascular disease was the leading cause in both groups (40.0% males, and 34.3% females). Notably, neurodegenerative disorders showed a significant gender difference, being more prevalent in females (31.4%) compared to males (20.0%) (P = 0.042). Other etiologies, including brain tumors, metabolic disorders, and posttraumatic causes, showed no significant gender differences [Table 2].
Table 2.
Etiology of seizures
| Etiology | Males (n=40), n (%) | Females (n=35), n (%) | P |
|---|---|---|---|
| Cerebrovascular disease | 16 (40.0) | 12 (34.3) | 0.608 |
| Neurodegenerative disorders | 8 (20.0) | 11 (31.4) | 0.042* |
| Brain tumors | 6 (15.0) | 4 (11.4) | 0.645 |
| Metabolic disorders | 4 (10.0) | 3 (8.6) | 0.834 |
| Posttraumatic | 3 (7.5) | 2 (5.7) | 0.756 |
| Cryptogenic | 3 (7.5) | 3 (8.6) | 0.867 |
*Statistically significant
MRI findings revealed cortical infarcts as the most common radiological finding in males (35.0%), whereas white matter changes were most prevalent in females (37.1%). Brain atrophy was more common in females (34.3%) compared to males (25.0%), although this the difference wasn’t statistically significant [Table 3].
Table 3.
Radiological findings on magnetic resonance imaging
| Finding | Males (n=40), n (%) | Females (n=35), n (%) | P |
|---|---|---|---|
| Cortical infarcts | 14 (35.0) | 10 (28.6) | 0.545 |
| White matter changes | 12 (30.0) | 13 (37.1) | 0.512 |
| Brain atrophy | 10 (25.0) | 12 (34.3) | 0.378 |
| Mass lesions | 6 (15.0) | 4 (11.4) | 0.645 |
| Hippocampal sclerosis | 3 (7.5) | 4 (11.4) | 0.567 |
| Normal imaging | 2 (5.0) | 1 (2.9) | 0.632 |
EEG findings showed similar patterns between genders. Normal background activity was observed in 37.5% of males and 34.3% of females. Focal epileptiform discharges were the most common abnormality in both groups (males: 55.0%, females: 51.4%) [Table 4].
Table 4.
Electroencephalographic findings
| EEG parameter | Males (n=40), n (%) | Females (n=35), n (%) | P |
|---|---|---|---|
| Background activity | |||
| Normal | 15 (37.5) | 12 (34.3) | 0.772 |
| Mild slowing | 14 (35.0) | 13 (37.1) | 0.845 |
| Moderate slowing | 8 (20.0) | 7 (20.0) | 1.000 |
| Severe slowing | 3 (7.5) | 3 (8.6) | 0.867 |
| Epileptiform discharges | |||
| Focal | 22 (55.0) | 18 (51.4) | 0.756 |
| Generalized | 8 (20.0) | 7 (20.0) | 1.000 |
| None | 10 (25.0) | 10 (28.6) | 0.723 |
EEG=Electroencephalographic
The distribution of seizure types was comparable between genders, with focal impaired awareness seizures being most common in both groups (males: 37.5%, females: 40.0%) [Table 5].
Table 5.
Seizure types and characteristics
| Characteristic | Males (n=40), n (%) | Females (n=35), n (%) | P |
|---|---|---|---|
| Seizure type | |||
| Focal aware | 12 (30.0) | 10 (28.6) | 0.892 |
| Focal impaired awareness | 15 (37.5) | 14 (40.0) | 0.824 |
| Focal to bilateral tonic-clonic | 8 (20.0) | 7 (20.0) | 1.000 |
| Generalized onset | 5 (12.5) | 4 (11.4) | 0.887 |
| Seizure frequency | |||
| <1 per month | 18 (45.0) | 16 (45.7) | 0.952 |
| 1–4 per month | 14 (35.0) | 12 (34.3) | 0.948 |
| >4 per month | 8 (20.0) | 7 (20.0) | 1.000 |
Treatment response patterns were similar between genders, with most patients responding to monotherapy (males: 60.0% and females: 62.9%). Complete seizure control was achieved in 65.0% of males and 68.6% of females, with no significant gender differences in treatment outcomes [Table 6].
Table 6.
Treatment response
| Parameter | Males (n=40), n (%) | Females (n=35), n (%) | P |
|---|---|---|---|
| AED usage | |||
| Monotherapy | 24 (60.0) | 22 (62.9) | 0.798 |
| Dual therapy | 12 (30.0) | 10 (28.6) | 0.892 |
| ≥3 AEDs | 4 (10.0) | 3 (8.6) | 0.834 |
| Seizure control | |||
| Complete control | 26 (65.0) | 24 (68.6) | 0.743 |
| Partial control | 10 (25.0) | 8 (22.9) | 0.828 |
| Poor control | 4 (10.0) | 3 (8.6) | 0.834 |
AED=Antiepileptic drug
DISCUSSION
The present study reveals important gender-specific patterns in seizure characteristics among elderly patients, with notable findings regarding etiology, radiological features, and treatment outcomes. These findings contribute to our understanding of age and gender-related aspects of epilepsy in the elderly population.
The predominance of cerebrovascular disease as the primary etiology in both genders (40.0% males and 34.3% females) aligns with recent epidemiological data. Stefanidou et al.[5] in their cohort study reported that cerebrovascular disease (hypertension) increases 2- to 2.5-fold the risk of developing late-onset epilepsy. This consistency across studies emphasizes the crucial role of vascular health in seizure prevention among older adults.
The significantly higher prevalence of neurodegenerative disorders in females (31.4% vs. 20.0%, P = 0.042) corresponds with findings from recent research. Lyou et al.[11] demonstrated in their 10-year cohort study that women over 60 have a higher association between Alzheimer’s disease and seizure occurrence, with a reported hazard ratio of 0.859 (95% confidence interval: 0.782–0.944). This gender disparity may be partially explained by the higher life expectancy in women and the increased prevalence of neurodegenerative conditions in elderly females.
Radiological findings in our study revealed distinct patterns between genders, with cortical infarcts predominating in males (35.0%) and white matter changes in females (37.1%). These findings align with recent work by Galovic et al.,[12] who identified gender-specific patterns in poststroke epilepsy development and associated imaging characteristics. The higher prevalence of brain atrophy in females (34.3% vs. 25.0%) warrants further investigation, particularly given emerging evidence about gender-specific patterns in brain aging.
The EEG findings showed consistency between genders, with focal epileptiform discharges being the predominant abnormality (males: 55.0%, females: 51.4%). This aligns with findings from Aanestad et al.,[13] who reported similar EEG patterns across genders in late-onset epilepsy, though they noted subtle differences in background activity that merit further investigation.
Treatment responses showed encouraging similarity between genders, with comparable rates of complete seizure control (65.0% males, 68.6% females). These findings support recent work by Sen A et al.,[14] who demonstrated that despite pharmacokinetic variations between elderly males and females, clinical outcomes remain similar with appropriate dosing strategies. The high rate of response to monotherapy in both groups (60.0% males and 62.9% females) suggests that single-drug regimens may be sufficient for many elderly patients, regardless of gender.
The high prevalence of comorbidities, particularly hypertension and diabetes, emphasizes the complexity of managing seizures in elderly populations. Recent research by Lattanzi S et al.[15] highlights the importance of considering these comorbidities in treatment selection, suggesting that a comprehensive approach to managing concurrent conditions may improve overall outcomes.
A notable limitation of our study is the relatively small sample size, which may have masked subtle gender-specific differences. Additionally, the cross-sectional nature of the study prevents analysis of long-term outcomes and disease progression patterns. Future longitudinal studies with larger cohorts are needed to better understand the temporal aspects of gender-specific differences in elderly-onset seizures.
CONCLUSIONS
The study reveals significant gender-specific patterns in the etiology of seizures among elderly patients, particularly in the prevalence of neurodegenerative disorders. While cerebrovascular disease remains the predominant cause in both genders, females showed a higher association with neurodegenerative conditions. Radiological and EEG findings demonstrated subtle gender differences, though treatment outcomes were comparable. These findings suggest the need for gender-specific considerations in the evaluation and management of elderly patients with seizures.
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
REFERENCES
- 1.Lezaic N, Roussy J, Masson H, Jetté N, Keezer MR. Epilepsy in the elderly: Unique challenges in an increasingly prevalent population. Epilepsy Behav. 2020;102:106724. doi: 10.1016/j.yebeh.2019.106724. [DOI] [PubMed] [Google Scholar]
- 2.GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:357–75. doi: 10.1016/S1474-4422(18)30454-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Galovic M, Ferreira-Atuesta C, Abraira L, Döhler N, Sinka L, Brigo F, et al. Seizures and epilepsy after stroke: Epidemiology, biomarkers and management. Drugs Aging. 2021;38:285–99. doi: 10.1007/s40266-021-00837-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: A 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279–86. doi: 10.1001/jamaneurol.2017.3949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Stefanidou M, Himali JJ, Devinsky O, Romero JR, Ikram MA, Beiser AS, et al. Vascular risk factors as predictors of epilepsy in older age: The Framingham heart study. Epilepsia. 2022;63:237–43. doi: 10.1111/epi.17108. [DOI] [PubMed] [Google Scholar]
- 6.Goodman AM, Szaflarski JP. Recent advances in neuroimaging of epilepsy. Neurotherapeutics. 2021;18:811–26. doi: 10.1007/s13311-021-01049-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li M, Huang L, Yang D, Luo C, Qin R, Zhang B, et al. Atrophy patterns of hippocampal subfields in T2DM patients with cognitive impairment. Endocrine. 2020;68:536–48. doi: 10.1007/s12020-020-02249-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Meyer M, Schmetsdorf S, Stein T, Niemöller U, Arnold A, Schramm P, et al. Electroencephalography findings in older adults undergoing geriatric treatment: A surrogate for the outcome? Brain Sci. 2022;12:839. doi: 10.3390/brainsci12070839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ramakrishnan S, Asuncion RM, Rayi A. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. [[Last updated on 2024 Apr 30]]. Localization-related epilepsies on EEG. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557645/ [PubMed] [Google Scholar]
- 10.Ghosh S, Jehi LE. New-onset epilepsy in the elderly: Challenges for the internist. Cleve Clin J Med. 2014;81:490–8. doi: 10.3949/ccjm.81a.13148. [DOI] [PubMed] [Google Scholar]
- 11.Lyou HJ, Seo KD, Lee JE, Pak HY, Lee JH. Association of Alzheimer's disease with the risk of developing epilepsy: A 10-year nationwide cohort study. Dement Neurocogn Disord. 2018;17:156–62. doi: 10.12779/dnd.2018.17.4.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Galovic M, Döhler N, Erdélyi-Canavese B, Felbecker A, Siebel P, Conrad J, et al. Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): A multivariable prediction model development and validation study. Lancet Neurol. 2018;17:143–52. doi: 10.1016/S1474-4422(17)30404-0. [DOI] [PubMed] [Google Scholar]
- 13.Aanestad E, Gilhus NE, Brogger J. Interictal epileptiform discharges vary across age groups. Clin Neurophysiol. 2020;131:25–33. doi: 10.1016/j.clinph.2019.09.017. [DOI] [PubMed] [Google Scholar]
- 14.Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. Lancet. 2020;395:735–48. doi: 10.1016/S0140-6736(19)33064-8. [DOI] [PubMed] [Google Scholar]
- 15.Lattanzi S, Trinka E, Del Giovane C, Nardone R, Silvestrini M, Brigo F. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis. Epilepsia. 2019;60:2245–54. doi: 10.1111/epi.16366. [DOI] [PubMed] [Google Scholar]
